Abstract
Asymptomatic internal carotid artery stenosis increases with age and is more common in men. Carotid endarterectomy and stenting have reduced stroke rates in patients with asymptomatic carotid stenosis in clinical trials. A variety of risk stratification methods are available for selection of patients with carotid stenosis for revascularization. In the past decade, there is increasing evidence that the rate of stroke declined with the use of aggressive multi-modal medical therapy. These developments have led to new clinical trials to compare revascularization versus aggressive medical therapy in patients with asymptomatic carotid stenosis.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Dharmasaroja P. Prevalence of extracranial carotid stenosis in Thai ischemic stroke/TIA patients. J Neurol Sci. 2008;269(1-2):92–5.
Fine-Edelstein JS et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology. 1994;44(6):1046.
de Weerd M et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke. 2010;41(6):1294–7.
Mannami T et al. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28(3):518–25.
Lim S et al. Subclinical atherosclerosis in a community-based elderly cohort: the Korean Longitudinal Study on Health and Aging. Int J Cardiol. 2012;155(1):126–33.
De Angelis M et al. Prevalence of carotid stenosis in type 2 diabetic patients asymptomatic for cerebrovascular disease. Diabetes Nutr Metab. 2003;16(1):48–55.
Luedemann J et al. Association between behavior-dependent cardiovascular risk factors and asymptomatic carotid atherosclerosis in a general population. Stroke. 2002;33(12):2929–35.
Mannami T et al. Comparison of the prevalence of asymptomatic carotid atherosclerosis detected by high-resolution ultrasonography in rural and urban middle-aged Japanese men. J Stroke Cerebrovasc Dis. 2000;9(3):106–12.
Signorelli SS et al. Ultrasound diagnosis of carotid artery lesions in a population of asymptomatic subjects presenting atherosclerosis risk factors. J Stroke Cerebrovasc Dis. 2004;13(3):95–8.
Bal SS et al. Association of metabolic syndrome with carotid atherosclerosis in the young North Indian population. Diabetes Metab Syndr. 2011;5(3):153–7.
Simons PC et al. Carotid artery stenosis in patients with peripheral arterial disease: the SMART study. SMART study group. J Vasc Surg. 1999;30(3):519–25.
Ahmed B, Al-Khaffaf H. Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis. Eur J Vasc Endovasc Surg. 2009;37(3):262–71.
Kim SJ et al. Biomarkers of asymptomatic carotid stenosis in patients undergoing coronary artery bypass grafting. Stroke. 2011;42(3):734–9.
Vranes M et al. Coexistence of internal carotid artery stenosis in patients with abdominal aortic aneurysm. Korean Circ J. 2013;43(8):550–6.
Ratchford EV et al. Carotid bruit for detection of hemodynamically significant carotid stenosis: the Northern Manhattan Study. Neurol Res. 2009;31(7):748–52.
Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007. 147;(12):854-9.
Moya A et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30(21):2631–71.
Langer-Gould AM et al. The American Academy of Neurology’s top five choosing wisely recommendations. Neurology. 2013;81(11):1004–11. Important societal statement cautions against unnecessary carotid imaging and intervention.
Dawkins AA et al. Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology. 2007;49(9):753–9.
Fifi JT et al. Complications of modern diagnostic cerebral angiography in an academic medical center. J Vasc Interv Radiol. 2009;20(4):442–7.
Thiex R, Norbash AM, Frerichs KU. The safety of dedicated-team catheter-based diagnostic cerebral angiography in the era of advanced noninvasive imaging. AJNR Am J Neuroradiol. 2010;31(2):230–4.
Nederkoorn PJ, van der Graaf Y, Hunink MG. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke. 2003;34(5):1324–32.
Jahromi AS et al. Sensitivity and specificity of color duplex ultrasound measurement in the estimation of internal carotid artery stenosis: a systematic review and meta-analysis. J Vasc Surg. 2005;41(6):962–72.
Koelemay MJ et al. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke. 2004;35(10):2306–12.
Townsend TC et al. Contrast material-enhanced MRA overestimates severity of carotid stenosis, compared with 3D time-of-flight MRA. J Vasc Surg. 2003;38(1):36–40.
Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40(10):e573–83.
Marquardt L et al. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke. 2010;41(1):e11–7.
Paraskevas KI et al. Identifying which patients with asymptomatic carotid stenosis could benefit from intervention. Stroke. 2014;45(12):3720–4. Excellent overview of current risk stratification techniques.
Markus HS et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol. 2010;9(7):663–71.
Topakian R et al. Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Neurology. 2011;77(8):751–8.
Kakkos SK et al. The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. J Vasc Surg. 2013;57(3):609–18. e1; discussion 617-8.
Silvestrini M et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA. 2000;283(16):2122–7.
Singh N et al. Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology. 2009;252(2):502–8.
Kakkos SK et al. Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg. 2009;49(4):902–9.
Silvestrini M et al. Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis. J Cereb Blood Flow Metab. 2013;33(4):619–24.
Takahashi W et al. Stroke risk of asymptomatic intra- and extracranial large-artery disease in apparently healthy adults. Cerebrovasc Dis. 2006;22(4):263–70.
Jahromi AS et al. Progression of internal carotid artery stenosis in patients with peripheral arterial occlusive disease. J Vasc Surg. 2009;50(2):292–8.
Amarenco P et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–59.
Ridker PM et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–207.
Halliday A et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746):1074–84.
Inzitari D et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med. 2000;342(23):1693–700.
Goldstein LB et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517–84.
Derdeyn CP et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383(9914):333–41. Important paper showing effectiveness of modern medical therapy.
den Hartog AG et al. Asymptomatic carotid artery stenosis and the risk of ischemic stroke according to subtype in patients with clinical manifest arterial disease. Stroke. 2013;44(4):1002–7. Valuable study of modern medical therapy and carotid stenosis stroke risk.
Spence JD et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010;67(2):180–6.
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273 (18):1421-8.
Tu JV et al. Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario Carotid Endarterectomy Registry. Stroke. 2003;34(11):2568–73.
Goldstein LB et al. Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis. Stroke. 1998;29(4):750–3.
Chaturvedi S et al. Carotid endarterectomy—an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65(6):794–801.
Yadav JS et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351(15):1493–501.
Brott TG et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.
Voeks JH et al. Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke. 2011;42(12):3484–90.
Nallamothu BK et al. Physician specialty and carotid stenting among elderly medicare beneficiaries in the United States. Arch Intern Med. 2011;171(20):1804–10.
Pahigiannis K, Kaufmann P, Koroshetz W. Carotid intervention: is it warranted in asymptomatic individuals if risk factors are aggressively managed? Stroke. 2014;45(3):e40–1.
Compliance with Ethics Guidelines
Conflict of Interest
S. Dharmadhikari declares no conflicts of interest.
S. Chaturvedi has served as a CREST 2 executive committee member and consultant at Mayo Clinic and has received a consultant fee as Chair, CREST stroke adjudications committee from the University of Medicine and Dentistry of New Jersey.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Cardiovascular Disease and Stroke
Rights and permissions
About this article
Cite this article
Dharmadhikari, S., Chaturvedi, S. Medical and Revascularization Therapies for Asymptomatic Carotid Stenosis. Curr Atheroscler Rep 17, 44 (2015). https://doi.org/10.1007/s11883-015-0522-9
Published:
DOI: https://doi.org/10.1007/s11883-015-0522-9